Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
For patients undergoing postoperative therapy for locally advanced gastric cancer after
neoadjuvant chemotherapy, we assessed the utility of graded histologic regression of <50% as
the criterion of treatment change. Sixty patients will be enrolled to randomize into two
groups：receiving modified chemotherapy and receiving the original chemotherapy.